17α-hydroxyprogesterone
- 1 lab in 1 country
- Humans1
Outcomes
1Cardiovascular events
no changein humans1
1 study
Cardiovascular events
no changein humans1
17α-hydroxyprogesterone has no effect on cardiovascular events in humans.
“There were no significant associations between 17α-hydroxyprogesterone levels and cardiovascular outcomes in either sex or the overall cohort.”
Humans
Circulating Androgen Precursors and Cardiovascular Risk: Insights From NHANES 2017-2023
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
1 in 12 monthsAHA Scientific Sessions 2025 Abstract
Circulating Androgen Precursors and Cardiovascular Risk: Insights From NHANES 2017-2023
Cross-sectional study of 5,545 peoplePopulations